Schedule 13G ownership disclosure

GAIN THERAPEUTICS INC

Security class unavailable · CUSIP: 36269B105

Event date: 2021-03-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
729,737
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001786406-21-000002
Form type
SC 13G/A
Filer
Gain Therapeutics, Inc.
CIK
CIK 1819411
Filed
Mar 29, 2021
Reporting period
Mar 29, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub